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Available online 1 December 2015AbstractPurpose: CT, MRCP and diffusion weighted imaging characteristics were discussed to improve the diagnostic accuracy of autoimmune
pancreatitis.
Materials and methods: 23 cases of confirmed autoimmune pancreatitis were retrospectively analyzed before treatments. 23 cases underwent CT
unenhanced and enhanced scans, 21 cases underwent MRCP examination, and 11 cases underwent DWI examination. Pancreatic lesion,
involvement of the pancreatic duct and bile duct, changes of adjacent artery and vein, and other organs lesions. CT values and ADC values of
pancreas and lesion were measured.
Results: Focal type lesions were shown in 6 cases, diffuse type in14 cases, and both types in 3 cases. Diffuse pancreatic swelling was shown in 20
cases, and peripancreatic halo in 13 cases. Mean CT values of lesions: unenhanced scan 35.81 ± 6.23 HU, late arterial phase 75.80 ± 17.47 HU,
venous phase 93.19 ± 14.06 HU, and equilibrium phase 90.00 ± 14.67HU. Delayed homogenous enhancement was shown in 17 cases. Tapered
narrowing (12 cases) or multiple segmental pancreatic duct stenosis (8 cases) was detected, the absence of main pancreatic duct dilatation or less
than 3.5 mm in 20 cases, and duct penetrating sign in 20 cases. Bile duct lesions were found in 20 cases. ADC values of lesions
(0.99 ± 0.03  103 mm2/s) were significantly lower that of pancreas (1.47 ± 0.16  103 mm2/s).
Conclusion: CT and MRI integrated diagnosis was helpful for accurate diagnosis based on the distinctive imaging characteristics of autoimmune
pancreatitis.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beijing You’an Hospital affiliated to Capital Medical University. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Autoimmune pancreatitis (AIP) is a special type of chronic
pancreatitis, with a incidence of 2%e11% [1,2]. AIP usually
occurs in people more than 50 years old, with a male to female
ratio of 3:1. The patients often present with jaundice, upper
abdominal pain, weight loss, fat diarrhea, nausea, vomiting,
etc, and acute onset of disease is rare. Etiology is still not clear
and considered related to immune adjustment disorder. The
diagnostic approach to AIP includes imaging, laboratory ex-
amination, histology, other organ involvement outside* Corresponding author.
E-mail address: mrpxl@126.com (J. Xie).
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open access article under the CC BY-NC-ND license (http://creativecommons.org/pancreas, reflection after steroid therapy [3,4]. Diagnosis
specificity and sensitivity of serological indexes, such as IgG4
and IgG, remain controversial, because the indexes don't in-
crease in some cases [3]. The specificity of the biopsy is not
high, which belongs to invasive examination [5]. All diag-
nostic criteria consider imaging as critical examination. CT
enhancement can evaluate the morphology and enhancement
degree of pancreas and its surrounding tissues, MRI can pro-
vide a higher resolution of soft tissue, MRCP has some ad-
vantages in evaluating the pancreatic duct and bile duct, and
DWI can provide histological information from view of mo-
lecular diffusion movement [6e8]. Integrated application of
these inspection methods could promote the accurate diagnosis
of the disease. Therefore, the purpose of this study is to
investigate integrated diagnosis value for autoimmune
pancreatitis (AIP) by dynamic enhanced CT, magneticof Beijing You’an Hospital affiliated to Capital Medical University. This is an
licenses/by-nc-nd/4.0/).
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weighted imaging (DWI).
2. Patients and methods2.1. SubjectsAccording to international consensus of AIP diagnostic
criteria of 2011 international association of pancreatic disease
[3], 23 cases of the AIP patients were retrospectively analyzed
since 2008. Among them, 6 cases were confirmed by surgery,
9 cases by endoscopic retrograde cholangiopancreatography
(ERCP) and biopsy, 8 cases by review after steroid therapy.
The study patients consisted of 3 women and 20 men (mean
age 63.2 ± 15 years). The main symptoms included jaundice,
abdominal pain, abdominal distention, diarrhea, angular, fa-
tigue, fever, etc, of which 13 cases jaundice. IgG4 increased in
3 cases, IgG increased in 6 cases, and IgE increased in 6
patients.2.2. CT and MRI parameters23 cases were consecutively referred for unenhancement
CT scan and late arterial (38e42 s) and venous phase
(60e65 s) enhancement scanning, of which 13 cases for
equilibrium phase (120 se180 s) examination before treat-
ment, with window width of 170 HU and window level of 35
HU. Spiral scan scope ranged from diaphragm to inferior
margin of sacroiliac joint in 23 cases. At the same time, 3
cases went through thorax scan, 2 cases pelvis scan, and 1 case
neck scan. CT scanner (Discovery HD 750, GE) was using,
and parameters were as follows: slice thickness 3.5 mm, slice
space 3.5 mm, careKV, detector width 64 * 2 * 0.6 mm, pitch
0.8, rotation speed 0.5 s. Contrast agent was non-ionic contrast
agent (Ioversol 350 mgI/ml, tyco healthcare, the United
States), 80 ml, injected with 3.0 ml/s by median cubital vein.
After the whole scan, the venous phase images were recon-
structed coronally, with slice thickness 3.5 mm and slice space
3.5 mm.
MRCP sequence was carried out for 21 cases AIP patients
before treatment, of which 11 for DWI examination. MRI
scanner was Siemens 3.0 T superconducting scanner (MAG-
NETOM TRIO TIM, Siemens, Erlangen, Germany), with b
value of 0 s/mm2, 500 s/mm2, 1000 s/mm2. Parameters are
shown in Table 1.Table 1
MRCP and DWI parameters.
TR/TE (ms) ETL FA () S
(m
T2 TSE 188/93 29 120 6
T1 FLASH-FS 174/2.46 70 5
Thick-section MRCPa 4500/751 307 180
Thin-section MRCP 1500/92
TI ¼ 200 ms
256 150 4
DWI 2100/73 6
a Slab thickness 60 mm.2.3. Image analysis and measurementsCT, MRCP and DWI sequence images were respectively
evaluated by two radiologists (12 years and 15 years CT and
MRI working experience), coming to an agreement after dis-
cussion. The location, shape and range of the lesion were
recorded. The enhancement degree and uniformity were
observed in CT enhanced image. The shapes of pancreatic duct
and bile duct were observed in MRCP images. At the same
time, the shape of whole pancreas and the surrounding
involvement, adjacent affected arteries and veins, and
concomitant lesions in other viscera were also recorded. DWI
features of AIP lesions and normal pancreatic tissues were
compared.
The whole pancreas was divided into three parts: head,
body and tail. The lesion, confined to one part as nodule, was
defined as the focal type. The lesion, distributed in the two or
more than two parts, was defined as the diffuse type. Lesion
with the two above distribution was defined as the mixed type.
For focal AIP type, CT values of unenhancement and
enhancement images and apparent diffusion coefficient (ADC)
values of the lesions and normal pancreatic parenchyma were
measured. For diffuse AIP type, CT values and ADC values of
lesions were measured. Regions of interest (ROI) of lesion
area were about 0.5e1 cm2, and normal pancreatic paren-
chyma ROIs were about 0.2e0.5 cm2. Fat tissue should be
avoid for patients with pancreas atrophy or fatty infiltration.
ADC values mean were calculated and compared between
lesions and normal pancreatic parenchyma. The average CT
value of lesions (unenhancement Du, late arterial phase Da,
venous phase Dv, and equilibrium phase De) and the CT value
ratio of lesion and normal pancreas (unenhancement Du/Pu,
late arterial phase Da/Pa, venous phase Dv/Pv, and equilibrium
phase De/Pe).2.4. PathologyPathologic results were available for 6 patients by sur-
geries, and 9 patients by ERCP and biopsies. Pathologist (with
9 years of experience in pancreas and hepatobiliary pathology)
reviewed the pathology slides and the macroscopic pictures of
the resected specimen with no knowledge of the imaging
findings. All surgery or biopsy specimens were fixed in 10%
neutral buffered formalin for 6e48 h, embedded in paraffin,
cut sections, and stained with hematoxylin-eosin (HE) forection thickness
m)
Slice gap (mm) FOV (mm) Matrix
1.2 380 320*320
1.0 350 320*256
320 512*307
0.4 340 320*256
1.2 350 192*120
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En Vision two footwork was used, including CD38, IgG, and
IgG4.2.5. Statistical analysisKappa test was used to evaluate the result consistency be-
tween two observers. The reference evaluation principle of the
Kappa value (K value): <0.8 K  1.0, diagnostic consistency
was wonderful; 0.4 < K  0.8, diagnostic consistency was
good; 0 < K  0.4, diagnostic consistency was bad, Signifi-
cant level for a ¼ 0.05. Statistical significance was calculated
using paired sample t test for CT value and ADC value
comparisons, and P < 0.05 was chosen as statistically
significant.
3. Results
23 AIP patients included focal type 6 cases (26.1%), diffuse
type 14 cases (60.9%) and combination type 3 cases (13.0%)
(Table 2). Focal type included 5 cases single lesion (2 in
pancreatic head and 3 in body and tail) (Fig. 1) and 1 case
multiple lesions. Diffuse type involved the whole pancreas
(Fig. 2). Combination type (focal and diffuse type coexisting)
involved the pancreatic head and body and tail (Fig. 3). CT
performance include pancreas local swelling or diffuse
enlargement as sausage, with uniform density, a low density
halo around the gland. In MR images, the lesions and halo are
shown slightly hyperintensity in T2WI and slightly hypo-
intensity in T1WI. The lesions were showed most clearly in T1
FLASH-FS sequence compared with other MR sequences and
CT images.
AIP lesions were shown homogeneous hypodensity in
unhancement CT scan, and uniform enhancement in three
phases images. In 17 (73.9%) cases, enhancement degree
increased gradually (Fig. 1AeC), of which lesion CT values of
8 cases were close to normal pancreaes in equilibrium phase.
For the other 6 cases (26.1%), enhancement degree did not
increased. CT value statistics of AIP lesions and CT value
ratio of lesion and normal pancreas were shown in Table 3.
21 cases MRCP performance: The pancreatic duct in part of
AIP lesions, was shown a tapered stenosis in 12 cases (57.1%)
(Fig. 1F), multiple segmental stenosis and skip distributed in 8
cases (38.1%) (Fig. 2E), and rough pancreatic duct without
stenosis in 1 case. Pancreatic duct are visible through AIP
lesion in 20 cases (95.2%), and only 1 case showed duct oc-
clusion. Upstream pancreatic duct did not show dilation in 11
cases, mild dilation (less than 3.5 mm) in 9 cases, and obviousTable 2
Lesion morphology and vascular involvement in AIP.
(n ¼ 23) Lesion Pancrease
Shape Size (cm) Sausage
Diffuse (n ¼ 14) Diffuse 14
Focal (n ¼ 6) Nodule 1.7e3.3 (2.2 ± 0.7) 3
Combination (n ¼ 3) 3dilation (7 mm) in 1 case. The pancreas atrophy was not found
in all cases. For 2 cases who only went through CT exami-
nation, pancreatic duct was not detected.
In 21 cases, 20 cases (95.2%) were accompanied with
different degrees of extrahepatic bile duct lesions. 15 cases
(71.4%) intrapancreatic portion of the common bile duct
showed tapered stenosis (Fig. 1F), 2 cases showed truncation
stenosis (Fig. 2E), 1 case showed rough bile duct wall, and 2
cases showed multiple strictures of common bile duct and
hepatic portal bile duct. 19 cases (90.5%) showed secondary
dilation of intrahepatic and extrahepatic bile duct, while 1 case
did not show dilation bile duct. In 20 cases with bile duct
lesion, 1 case with AIP lesion confined in the body, still was
accompanied with bile duct wall thickening, luminal stenosis
and secondary dilation. 2 cases with biliary drainage tube only
went through the CT examination, so it was difficult to judge
the stenosis degree of bile duct.
11 cases AIP lesions were shown slightly higher intensity
than the pancreas (Fig. 1G), and average ADC values of le-
sions was 0.99 ± 0.03  103 mm2/s. Normal pancreas average
ADC values was 1.47 ± 0.16  103 mm2/s. ADC of AIP le-
sions values were less than normal pancreatic tissue (Fig. 1H),
with significant difference (P < 0.001).
In 23 cases, 3 cases involved multiple blood vessels,
including pulmonary arteries, abdominal aorta, subclavian
artery and inferior mesenteric artery, iliac artery, characterized
by wall thickening and cavity expansion; 3 cases involved both
kidneys, detected as multiple focal lesions with mild or
moderate enhancement; 2 cases involved lymph nodes,
including submandibular region, parotid gland, jugular vein
region, supraclavicular, axillary, lung hilus, mediastinum, re-
gion of abdominal aorta and iliac blood vessels, and groin; 1
case appeared mesenteric effusion; and 1 case appeared sub-
mandibular gland enlargement.
15 cases pathological examination showed different degree
of pancreatic ductal wall thickening, periductal lymphocytes
and plasma cells infiltration with varying degree of fibrosis,
and occlusive phlebitis. IgG4 positive plasma cell infiltration
appeared in 3 cases.
4. Discussion4.1. AIP lesionTypical AIP was characterized by pancreas diffuse
enlargement as sausage shape, uniform density, mild or
moderate enhancement, and low density halo around pan-
crease [9]. The literature reported 57 cases AIP, diffuse (44%),Vascular involvement
Atrophy Halo Splenic artery Splenic vein Portal vein
no 8 3 8
no 4 1 1 1
no 1 1
Fig. 1. M/75. Focal lesion in pancreatic head. Unhancement CT image (A) showed lightly low density, late arterial phase (B), venous phase (C) images showed
enhanced uniformly and gradually. MR T1FS (D) showed slightly hypointensity in T1WI, and slightly hyperintensity in TSE FS T2WI (E). MRCP (F)showed
narrowing of the pancreatic head duct and mild upstream pancreatic duct dilatation, and gradual stenosis of intrapancreatic portion of the common bile duct and
obvious dilatation of intrahepatic and extrahepatic bile duct. DWI (G) showed slightly hyperintensity lesion, and ADC map (H) showed hypointensity.
Hematoxylin-eosin [HeE] stain, original magnification, 200 (I) showed thickening of the pancreatic duct wall, periductal inflammation associated with fibrosis,
and obliterative phlebitis. IgG4 immunostain; original magnification, 400 (J) shows IgG4-positive plasma cells around the pancreatic duct.
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combination type and multiple focal were majority (78.3%,
18/23), while single focal type was minority (21.7%,5/23), that
the difference may be associated with less number of cases.Fig. 2. M/63. Diffuse AIP. Venous phase CT image (A) showed diffuse enlargemen
reconstruction (B) showed stenosis of intrapancreatic portion of the common bile du
diffuse enlargement and a hypointensity halo. MRCP (E) showed multiple narrowi
intrapancreatic portion of the common bile duct with obvious dilatation of intrahePancreatic atrophy was not seen in AIP. Sausage shaped
pancreas and halo sign were observed in the majority of cases,
from the previous literature and our cases [11]. Because
normal pancreatic tissue was characterized by high signal int, with a low density halo and stenosis of splenic vein. Venous phase coronal
ct and thickening of wall. MRT2WI TSE (C) and FS T1WI (D) images showed
ng of pancreatic duct without upstream duct dilatation, and cutting stenosis of
patic and extrahepatic bile duct.
Fig. 3. M/63. Diffuse AIP in body and tail combined with focal lesion in head. Venous phase CT image showed uniform enhanced lesion in head (A) and diffuse
enlargement in body and tail (B). MR FS T1WI showed lightly hypointensity lesions in head (C) and body and tail (D).
Table 3
CT value of AIP lesions and CT value ratio of lesion and normal pancreasa.
AIP Normal pancreas T P
Unhancement 35.81 ± 6.23 41.23 ± 6.65 2.454 0.020
Late arterial phase 75.80 ± 17.47 97.99 ± 6.04 3.224 0.003
Venous phase 93.19 ± 14.06 103.24 ± 15.38 2.100 0.043
Equilibrium phase 90.00 ± 14.67 95.56 ± 5.73 0.758 >0.05
a For the case that lesion involved the whole pancrease, normal pancreatic
tissue CT value did not be measured.
166 X. Pei et al. / Radiology of Infectious Diseases 2 (2015) 162e167MR T1WI fat suppression sequence images, so the contrast
between pancrease and AIP lesions was more prominent in the
sequence, compared with unhancement CT scan images.
AIP lesions were characterized by uniform and low density
in three enhancement phases, and most AIP lesions were
enhanced obviously in venous phase and equilibrium phase,
even close to the pancreas tissue density. This sign may be due
to lymphocytes and plasma cells diffuse infiltration and fibrous
tissue hyperplasia leading to slow contrast dispersion, and
occlusive phlebitis restricting contrast agent elimination [12].
In this study, 47.8% (11/23) cases involved blood vessels,
such as the splenic artery and vein and portal vein, and did not
involved the superior mesenteric artery and pan-
creaticoduodenal artery. These cases mainly were diffuse type
lesions, so it was concluded that blood vessels involving may
be related to the location and larger scope of the diffuse
lesions.4.2. Involved pancreatic duct and bile ductCT enhancement images can display the expansion of the
pancreatic duct and bile duct, and scope and enhancement
degree of thickening bile duct wall. MRCP was more sensitive
than CT in showing the pancreatic duct and bile duct, espe-
cially for mild expansion or normal diameter duct [12,13]. In
our most cases, the main pancreatic ducts were tapered or
multiple segments narrowing, and upstream pancreatic duct
expansion appeared less (47.6%, 10/21), even in cases with the
pancreatic duct expansion, the expansion degree of most were
less than 3.5 mm. Many literatures considered that the main
pancreatic duct multiple irregular stenosis without the
expansion of the upstream pancreatic duct (<5 mm)is one of
the characteristics of AIP [11e16]. At the same time,
pancreatic duct penetrating sign shown in our vast majority ofcases, was considered as one of characteristics of the AIP [15],
with sensitivity 73% and specificity 96%.
Bile ducts is the most common AIP involvement location
except pancreas [17], especially lower part of bile duct. pe-
ripheral lymphocyte and plasma cell infiltration and fibrous
tissue hyperplasia induced bile duct wall thickening and
slender centrality narrow of duct lumen. In our study, 87.0%
(20/23) cases involved common bile duct, consistent with
literature reports. Besides, 1 case of focal lesion far from
pancreatic head still was companied with common bile duct
involvement, and 2 cases showed multiple segments stenosis
of bile duct, which probably was significantly for the diagnosis
of AIP.4.3. DWIIn this study, ADC values of AIP lesions were significantly
less than the normal pancreatic tissue [18,19], that was
consistent with previous literature. Its pathological basis was
still not clear, and was considered associated with the
following factors: increase of cell components such as lym-
phocytes and plasma cells, and fiber tissue hyperplasia, made
water molecules diffusion limited. ADC values had higher
accuracy for AIP diagnosis. The optimal ADC cutoff value
was 0.88 * 10-3 mm2/s to distinguish AIP from pancreatic
cancer, with the sensitivity of 100%, specificity of 89% [18].
ADC values varied slightly in different literatures, that may
be related to some factors, such as the MRI scanner type, field
strength, choice of b value, and the type of DWI sequence,
et al. Higher b value should be chosen to reduce the T2
shining effect, perfusion effect, and background tissue signal
[19].4.4. Extrapancreatic lesionsIn previous literatures, extrapancreatic involvements
include: bile duct (77%), renal (35%), lymph nodes (33%),
gall bladder (16%), retroperitoneal and mesenteric, thyroid,
lacrimal gland, orbit, salivary gland, lung, gastrointestinal
tract, and blood vessels, et al. [20e23]. Its pathological basis
was uniform to pancreas AIP. Our cases involved blood ves-
sels, kidneys, lymph nodes, mesenteric, submandibular gland.
The less involvement organs may be associated with less cases
of this group. These signs were of great help for the differ-
ential diagnosis of AIP.
167X. Pei et al. / Radiology of Infectious Diseases 2 (2015) 162e1674.5. Differential diagnosisDue to the pancreatic duct and bile duct stenosis and sec-
ondary upstream duct dilation in most of AIP cases, especially
focal lesions, so these often were distinguished from pancre-
atic ductal adenocarcinoma. The following points were helpful
[12,18]: (1) typical pancreatic cancer usually was shown as
nodular, with secondary upstream pancreatic duct dilation
(>5 mm) and pancreatic parenchyma atrophy. (2) involved
common bile ducts often were shown as truncated narrowing,
and lesions in body or tail did not affect the bile duct. (3)
pancreatic cancer frequently oppressed or invaded adjacent
organs, such as duodenum, stomach, and blood vessels, with
intraperitoneal or retroperitoneal lymph node metastasis, and
metastasis of distant organs, such as liver, lung et al., in late
stage.
5. Conclusion
In conclusion, the imaging findings of AIP were compli-
cated, including pancreas swelling like sausage shape, with
circumambient halo and delay enhancement in portal venous
or equilibrium phase, without obvious upstream pancreatic
duct dilation. ADC value of AIP was significantly less than
pancreas, often accompanied by lesions of other organs.
Fully understanding these signs and choosing the appropriate
examination way had a high clinical value for correct
diagnosis.
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